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Abstract
Objective:  To  evaluate  the  performance  of  the  Pediatric  Index  of  Mortality  2  (PIM2)  in  a
pediatric intensive  care  unit  (PICU)  with  a  high  prevalence  of  patients  with  complex  chronic
conditions  (CCCs),  and  compare  the  performance  between  patients  with  and  without  CCCs.
Methods:  A  prospective  cohort  study  was  conducted  in  a  PICU  in  Brazil,  with  patients  admitted
between 2009  and  2011.  The  performance  was  evaluated  through  discrimination  and  calibration.
Discrimination  was  assessed  by  calculating  the  area  under  the  ROC  curve,  and  calibration  was
determined  using  the  Hosmer-Lemeshow  goodness-of-ﬁt  test.
Results: A  total  of  677  patients  were  included  in  the  study,  of  which  83.9%  had  a  CCC.  Overall
mortality was  9.7%,  with  a  trend  of  higher  mortality  among  patients  with  CCCs  when  com-
pared  to  patients  without  CCCs  (10.3%  vs.  6.4%,  p  =  0.27),  but  with  no  difference  in  the  mean
probability  of  death  estimated  by  PIM2  (5.9%  vs.  5.6%,  p  =  0.5).  Discrimination  was  considered
adequate in  the  general  population  (0.840)  and  in  patients  with  and  without  CCCs  (0.826  and
0.944).  Calibration  was  considered  inadequate  in  the  general  population  and  in  patients  with
CCCs  (p  <  0.0001  and  p  <  0.0001),  but  it  was  considered  adequate  in  patients  without  CCCs
(p  =  0.527).
Conclusions:  PIM2  showed  poor  performance  in  patients  with  CCCs  and  in  the  general  popu-
lation. This  result  may  be  secondary  to  differences  in  the  characteristics  between  the  study
samples  (high  prevalence  of  patients  with  CCCs);  the  performance  of  the  PIM2  should  not  be
ruled  out.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
 Please cite this article as: Fonseca JG, Ferreira AR. Application of the Pediatric Index of Mortality 2 in pediatric patients with complex
hronic conditions. J Pediatr (Rio J). 2014;90:506--11.
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Aplicac¸ão  do  Pediatric  Index  of  Mortality  2  em  pacientes  pediátricos  com  condic¸ão
crônica  complexa
Resumo
Objetivo:  Avaliar  o  desempenho  do  Pediatric  Index  of  Mortality  2  (PIM2)  em  Unidade  de  Terapia
Intensiva Pediátrica  (UTIP)  com  alta  prevalência  de  pacientes  com  condic¸ões  crônicas  complexas
(CCC),  e  comparar  o  desempenho  entre  pacientes  com  e  sem  CCC.
Métodos: Estudo  de  coorte  prospectivo,  realizado  em  UTIP  no  Brasil,  com  pacientes  admiti-
dos entre  2009  e  2011.  O  desempenho  foi  avaliado  através  da  discriminac¸ão  e  calibrac¸ão.  A
discriminac¸ão  foi  avaliada  através  do  cálculo  da  área  sob  a  curva  ROC  e  a  calibrac¸ão  através  do
teste  de  ajuste  de  Hosmer-Lemeshow.
Resultados: Foram  incluídos  no  estudo  677  pacientes,  com  83,9%  deles  apresentando  uma  CCC.
A  mortalidade  geral  foi  9,7%,  com  tendência  de  maior  mortalidade  entre  pacientes  com  CCC
quando  comparados  com  pacientes  sem  CCC  (10,3%  vs.  6,4%;  p  =  0,27),  porém  sem  diferenc¸a na
média  de  probabilidade  de  morte  estimada  pelo  PIM2  (5,9%  vs.  5,6%;  p  =  0,5).  A  discriminac¸ão
foi considerada  adequada  na  populac¸ão  geral  (0,840)  e  nos  pacientes  com  e  sem  CCC  (0,826  e
0,944).  A  calibrac¸ão  foi  considerada  inadequada  na  populac¸ão  geral  e  nos  pacientes  com  CCC
(p  <  0,0001  e  p  <  0,0001),  porém  foi  considerada  adequada  nos  pacientes  sem  CCC  (p  =  0,527).
Conclusões:  O  PIM2  apresentou  desempenho  inadequado  nos  pacientes  com  CCC  e  na  populac¸ão
geral. O  desempenho  inadequado  pode  ser  secundário  à  diferenc¸a das  características  entre  as
amostras  do  estudo  (alta  prevalência  de  pacientes  com  CCC),  e  o  desenvolvimento  do  escore
não  pode  ser  descartado.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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ste é Introduction
Children  with  complex  chronic  conditions  (CCCs)  are  charac-
terized by  the  presence  of  any  medical  condition  in  which
the pathology  duration  is  expected  to  last  at  least  12  months
(except when  the  patient  dies),  affecting  any  body  system  or
organ severely  enough  to  require  care  from  a  pediatric  spe-
cialty, and  probably  requiring  hospitalization  in  a  tertiary
hospital.1
There  is  an  increased  prevalence  of  children  with  CCCs
admitted to  the  pediatric  intensive  care  unit  (PICU),  with
the observation  that  patients  with  CCCs  have  higher  risk
of mortality  and  increased  length  of  stay  in  the  PICU  when
compared to  patients  without  CCCs.2
Outcome  prediction  scores  are  tools  that  quantify  the
patient’s clinical  condition  severity  and  predict  mortality,
and are  considered  important  components  to  measure  and
improve the  quality  of  care  offered  in  the  PICU.3 The  two
most commonly  used  outcome  prediction  scores  in  the  pedi-
atric population,  the  Pediatric  Index  of  Mortality  2  (PIM2)4
and  Pediatric  Risk  of  Mortality  III  (PRISM  III),5 include  fewer
chronic conditions  as  prediction  variables  in  their  models.
Based  on  the  concept  that  outcome  prediction  scores
might not  work  properly  in  a  setting  where  patient  charac-
teristics or  diagnoses  are  substantially  different  from  those
of patients  used  in  the  development  of  the  score,4 and
the observation  of  the  increased  prevalence  of  children
admitted to  the  PICU  with  CCCs  in  recent  years,  who  had
higher mortality  rates  than  patients  without  CCCs,2 it  was
considered important  to  evaluate  the  performance  of  out-
Ecome prediction  scores  in  a  setting  that  would  reﬂect  these
changes.
The aim  of  this  study  was  to  evaluate  the  performance  of
the PIM2  score  for  predicting  outcomes  in  a  PICU  with  high
t
s
hrevalence  of  patients  with  CCCs,  and  to  compare  the  score
erformance between  patients  with  and  without  CCCs.
ethods
his  study  was  approved  by  the  Research  Ethics  Committee
f Universidade  Federal  de  Minas  Gerais,  Belo  Horizonte,
razil, and  an  informed  consent  was  obtained  for  all  partic-
pants.
A prospective  cohort  study  was  conductions  in  the  PICU
f the  Hospital  das  Clínicas.  The  PICU  has  ten  beds,  with
pproximately 370  admissions  per  year,  both  clinical  and
urgical, including  cardiac  surgery.
All  patients  admitted  to  the  PICU  between  February  1,
009 and  January  31,  2011  were  included  in  the  study.
atients younger  than  30  days  or  older  than  18  years,
atients who  died  within  the  ﬁrst  two  hours  of  admission,
atients with  suspected  brain  death  at  admission  that  was
ater conﬁrmed,  patients  considered  as  having  no  chance
f curative  treatment  (NCCT),  and  patients  whose  par-
nts/guardians did  not  sign  the  consent  form  were  excluded
rom the  study.
The study  variables  were  those  used  to  characterize  the
atients, death  probability  calculated  by  PIM2,  and  out-
ome variables.  The  data  from  the  analyzed  variables  were
ollected by  the  researchers  from  the  medical  and  nursing
ecords.
For patient  characterization,  the  following  data  were
valuated: age,  gender,  presence  of  CCC,  type  of  CCC,  type
f admission  (medical  or  surgical),  type  of  clinical  pathology,
um artigo Open Access sob a licença de CC BY-NC-NDype of  surgical  pathology,  elective  or  non-elective  admis-
ion condition,  and  use  of  invasive  mechanical  ventilation.
The  presence  of  CCC  was  recorded  when  the  patient
ad any  medical  condition  characterized  by  pathology
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208  
uration  of  at  least  12  months  (except  when  the  patient
ied) that  affected  any  body  system  or  organ  severely
nough to  require  care  from  a  pediatric  specialty,  and
robably requiring  hospitalization  in  a  tertiary  hospital.1
he  patient’s  CCC  was  classiﬁed  according  to  the  clas-
iﬁcation developed  by  Feudtner  et  al.:1 neuromuscular
alformations;  cardiovascular  malformations;  respiratory,
enal, gastrointestinal,  hematological  or  immunological,
nd metabolic;  other  genetic  or  congenital  defects;  and
eoplasms.
The patient  was  classiﬁed  as  having  a  clinical  pathology  in
he presence  of  cardiovascular,  respiratory,  renal,  hepatic,
eurological, post-cardiorespiratory  arrest,  or  oncologi-
al/hematological diseases.  The  patient  was  classiﬁed  as
aving a  surgical  pathology  in  the  presence  of  cardiovascu-
ar, neurological,  general  surgery,  orthopedic,  transplants,
r cardiac  catheterization  procedures.  The  admission  was
onsidered elective  when  the  PICU  admission  or  surgery
ould be  postponed  for  more  than  six  hours  without  adverse
ffects upon  the  patient.  The  probability  of  death  for  each
atient was  calculated  using  the  instructions  provided  by  the
uthors of  the  PIM2  score.4 The  analyzed  outcome  variables
ere PICU  discharge  event  (discharge  or  death)  and  length
f hospitalization.
Descriptive statistics  were  used  to  characterize  the
atients, and  the  PIM2  performance  was  assessed  by  meas-
res of  score  discrimination  and  calibration.  Discrimination
as assessed  by  calculating  the  area  under  the  receiver
perator characteristic  (ROC)  curve,6 and  was  considered
dequate when  the  area  was  >  0.7.7 Calibration  was  assessed
sing the  Hosmer-Lemeshow  goodness-of-ﬁt  test,6 and  was
onsidered appropriate  when  the  p-value  of  the  test  was  >
.05.7 In  the  Hosmer-Lemeshow  test,  patients  were  divided
nto ten  groups  with  increasing  risk  probability  and  a  similar
umber of  cases  in  each  group.
The  comparison  between  the  mortality  rate  in  the  study
opulation with  the  mortality  predicted  by  PIM2  score  was
erformed by  dividing  the  observed  mortality  rate  by  the
xpected mortality  rate  (as  calculated  by  the  score),  termed
he standardized  mortality  rate  (SMR).8 The  SMR  was  shown
ith its  95%  conﬁdence  interval  (95%  CI).  If  the  95%  CI  of  the
MR included  1,  its  performance  was  considered  medium;  if
he 95%  CI  of  the  SMR  had  an  upper  limit  <  1,  its  performance
as considered  good;  and  if  the  95%  CI  of  the  SMR  had  a  lower
imit >  1,  its  performance  was  considered  poor.9 All  analyses
ere performed  using  SPSS  Statistics  for  Windows  release  12
or Windows  (SPSS,  Chicago,  Illinois,  United  States).
esults
uring  the  study  period,  756  patients  were  admitted  to  the
ICU, of  whom  79  were  excluded:  63  patients  were  younger
han 30  days  old,  ten  patients  were  considered  NCCT,  four
atients died  within  the  ﬁrst  two  hours  after  admission  to
he unit,  and  two  patients  had  a  suspected  diagnosis  of  brain
eath on  admission,  which  was  later  conﬁrmed.  A  total  of
77 patients  were  included  in  the  study,  of  whom  568  (83.9%)
ad a  CCC.
The main  clinical  characteristics  of  the  general  popula-
ion and  the  subgroups  of  patients  with  and  without  CCC
re shown  in  Table  1.  The  median  length  of  stay,  mortality
a
o
vFonseca  JG,  Ferreira  AR
ates,  and  mean  probability  of  death  estimated  by  PIM2  and
MR of  the  general  population  and  subgroups  are  shown  in
able 1.  When  comparing  patients  with  and  without  CCC,
o statistically  signiﬁcant  difference  was  observed  in  the
edian length  of  stay  in  PICU  (3  days  vs.  3  days;  p  =  0.84),
n mortality  (10.3%  vs.  6.4%,  p  =  0.27),  and  in  the  mean
robability of  death  estimated  by  PIM2  (5.9%  vs.  5.6%,  p  =
.5).
The score  discrimination  assessed  by  the  area  under  the
OC curve  was  considered  adequate  both  in  the  general  pop-
lation and  in  the  subgroups  of  patients  with  and  without
CC (Table  2).  The  score  calibration  assessed  by  the  Hosmer-
emeshow goodness-of-ﬁt  test  was  considered  inadequate  in
he general  population  and  in  the  subgroup  of  patients  with
CC, but  it  was  considered  appropriate  in  the  subgroup  of
atients without  CCC  (Table  2).
iscussion
he  PIM2  score  was  chosen  for  evaluation,  as  it  is  considered
o be  user-friendly  and  efﬁcient,  and  it  is  public  domain.10
he  PIM2  is  the  updated  version  of  the  Pediatric  Index  of
ortality that  was  published  in  1997,  and  has  been  used
xtensively since  then.11,12
Since  its  publication  in  2003,  several  studies  have  been
ublished evaluating  the  score  performance  in  populations
nd scenarios  that  were  different  from  those  used  in  the
core development  study,  with  most  studies  showing  ade-
uate score  performance.10
In  the  present  study,  83.9%  of  patients  admitted  to  the
ICU had  one  CCC,  higher  values  than  those  found  in  a
ecent study  that  found  a  prevalence  of  53%  in  a  cohort  that
ncluded patients  from  54  PICUs  in  the  United  States.2 The
igh proportion  of  patients  with  CCCs  that  was  observed  in
he present  study  and  in  the  recent  literature  may  be  related
o advances  in  medical  care  in  recent  years,  especially  in
ediatric and  neonatal  intensive  care,  which  have  resulted
n improvement  in  survival  rates  of  patients  with  previously
nmanageable diseases,  leading  to  an  increase  of  patients
ith CCCs,  who  have  higher  risk  of  hospitalization  in  the
ICU than  the  general  population.13,14
The  overall  mortality  of  the  study  population  was  9.7%,
onsistent with  the  currently  observed  rates  in  the  PICUs,
hich range  from  5-10%.15 There  was  a  trend  toward
igher mortality  in  patients  with  CCCs,  when  compared  with
atients without  CCCs,  but  without  statistical  signiﬁcance.
The  observation  that  patients  with  chronic  diseases  have
igher mortality  rates  when  admitted  to  the  PICU  has  been
eported in  recent  literature.  Wölﬂer  et  al.,  in  a  study
valuating the  PIM2,  observed  a  high  mortality  in  patients
ith chronic  diseases  compared  with  the  general  population
15.6% vs.  5.2%).16 Odetola  et  al.  observed  a  signiﬁcantly
igher mortality  in  patients  with  comorbidities  when  com-
ared to  patients  without  comorbidities  admitted  to  the
ICUs in  the  United  States  in  1997  (12.5%  vs.  8.6%)  and  in
006 (10.8%  vs.  7.8%).17Edwards  et  al.  also  observed  a higher  mortality  rate
mong patients  with  CCCs,  when  compared  to  patients  with-
ut CCCs  admitted  to  PICUs  in  the  United  States  in  2008  (3.9%
s. 2.2%).2
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Table  1  Characteristics  of  the  general  population  and  subgroups  evaluated.
Characteristics  (%)  General  population  (677
patients)
Patients with  CCC
(568 patients)
Patients  without
CCC (109  patients)
Age  (months)  59  (13-122)a 64  (17-123)a 18  (5-82)a
Male  gender  349  (51.5%)  287  (50.5%)  62  (56.8%)
Complex chronic  condition  568  (83.9%)
Clinical  admission  320  (47.3%)  248  (43.6%)  72  (66%)
Surgical admission 357 (52.7%) 320  (56.3%)  37  (33.9%)
Invasive mechanical  ventilation 370  (54.6%) 322  (53.8%) 48  (44%)
Non-elective admission 320 (47.2%) 243  (42.8%) 77  (70.6%)
Types of  CCC
Neoplasias  171  (30.1%)
Cardiovascular  malformations  154  (27.1%)
Neuromuscular  malformations  64  (11.2%)
Gastrointestinal  55  (9.6%)
Renal  49  (8.6%)
Respiratory  27  (4.7%)
Other  genetic  or  congenital  defects  20  (3.5%)
Hematological  or  immunological  19  (3.3%)
Metabolic  9  (1.5%)
Reason  for  clinical  admission
Respiratory 134  (41.8%)  95  (38.3%)  39  (54.1%)
Circulatory 76  (23.7%)  69  (27.8%)  7  (9.7%)
Neurological 32  (10%)  22  (8.8%)  10  (13.8%)
Others 25  (7.8%)  21  (8.4%)  4  (5.5%)
Hepatic 19  (5.9%)  14  (5.6%)  5  (6.9%)
Post-CRA 18  (5.6%)  14  (5.6%)  4  (5.5%)
Onco-hematologic  9  (2.8%)  9  (3.6%)  0  (0%)
Renal 7  (2.1%)  4  (1.6%)  3  (4.1%)
Type of  surgery  performed
Pediatric general  surgery  105  (29.4%)  86  (26.8%)  19  (51.3%)
Neurosurgery 91  (25.4%)  76  (23.7%)  15  (40.5%)
Cardiovascular surgery  84  (23.5%)  83  (25.9%)  1  (2.7%)
Hemodynamics 39  (10.9%)  39  (12.1%)  0  (0%)
Transplant 17  (4.7%)  17  (5.3%)  0  (0%)
Others 12  (3.3%)  11  (3.4%)  1  (2.7%)
Orthopedic 9  (2.5%)  8  (2.5%)  1  (2.7%)
Length of  stay  4  daysb 3  daysb 3  daysb
Estimated  mortality  by  PIM2  5.9%  5.9%  5.6%
Mortality 9.7%  10.3%  6.4%
SMR 1.65  (1.26-2.04)a 1.75  (1.31-2.19)a 1.14  (0.29-1.99)a
CCC, complex chronic condition; CRA, cardiac arrest; PIM2, pediatric index of mortality 2; SMR, standardized mortality rate.
a 95% conﬁdence interval.
b median.However,  this  trend  of  increased  mortality  in  patients
with CCCs  in  the  present  study  was  not  veriﬁed  by  the
probability of  death  estimated  by  PIM2,  which  was  similar
in patients  with  and  without  CCCs  (5.9%  vs.  5.6%,  p  =  0.5)
a
w
p
i
Table  2  Performance  of  PIM2  in  the  general  population  and  subg
Categories  Area  under  ROC  cu
General  0.840  (0.810-0.867
Complex  chronic  condition  0.826  (0.792-0.856
No  complex  chronic  condition  0.944  (0.883-0.979
ROC, receiver operator characteristic; X2, chi-squared; HL, Hosmer-Lend  may  indicate  poor  score  performance.  This  observation
as also  reported  by  Edwards  et  al.,  who  demonstrated  that
atients with  CCCs  had  signiﬁcantly  higher  risk  of  mortality
n the  PICU  than  that  predicted  by  the  PIM2.2
roups.
rve  HL  test  X2 HL  test  p
)  43.405  <  0.0001
)  36.38  <  0.0001
)  7.089  0.527
meshow.
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Therefore,  it  can  be  hypothesized  that  the  differences
n characteristics  of  patients  with  CCCs  in  the  present  study
n relation  to  the  population  used  for  the  score  develop-
ent could  explain  the  poor  performance  of  the  PIM2,  as
eported by  the  authors  who  afﬁrm  that  the  differences  in
haracteristics and  diagnoses  of  a  population,  when  com-
ared with  the  population  used  in  the  score  development,
an result  in  poor  performance  of  the  score  when  evaluated
n a  new  scenario.4 It  is  important  to  emphasize  that  there
re no  data  on  the  prevalence  of  CCCs  in  the  population
sed for  the  development  of  the  PIM2,  but  some  chronic
iseases are  outcome  variables,  such  as  severe  combined
mmunodeﬁciency and  neurodegenerative  disease.4
When  evaluating  the  PIM2  performance,  the  score  was
onsidered inadequate  for  both  the  total  sample  and  the
ubgroup of  patients  with  CCCs  as  a  result  of  inefﬁcient  cal-
bration measured  by  the  Hosmer-Lemeshow  goodness-of-ﬁt
est, although  the  score  showed  adequate  performance  in
atients without  CCCs.
The  interpretation  of  the  Hosmer-Lemeshow  test  results
hen scores  are  applied  to  new  populations  should  be  car-
ied out  carefully,  due  to  the  fact  that  possible  external
actors, such  as  sample  size,  can  inﬂuence  the  test’s  p-
alue.18
Marcin  et  al.  reported  that  when  the  calibration  is  eval-
ated in  a  sample  independent  from  the  score  development
ample, inadequate  calibration  may  result  from  an  inade-
uate score,  but  it  can  also  be  an  indicator  of  differences
n quality  of  care  offered  between  the  study  samples  and
hose used  for  the  score  development.3
In  situations  in  which  the  evaluation  of  the  score
onducted in  an  independent  sample  shows  inadequate  per-
ormance, some  questions  should  be  answered:19 Is  the
ifference in  performance  related  to  the  staff  responsible
or patient  care?  Do  the  diagnostic  and  therapeutic  options
ave similar  accessibility  and  use?  Is  the  health  system,  of
hich the  PICU  is  part,  efﬁcient?  Was  data  collection  ade-
uate? Is  the  score  not  appropriate  for  a  different  mix  of
ases?
The study  design  does  not  allow  for  the  answering  of  the
rst three  questions,  which  are  related  to  the  quality  of
ealth care  offered  in  the  studied  PICU.  However,  it  may
e noted  that  the  unit  is  part  of  a  public  health  system  in
 developing  country,  facing  difﬁculties  related  to  funding,
tructure, personnel,  and  operational  organization,  which
an negatively  affect  the  quality  of  health  care  offered  to
atients.
The fourth  question  can  be  answered  through  the
ethodology used  to  collect  data  from  the  study,  which  fol-
owed  the  guidelines  proposed  by  the  authors  of  the  PIM2.4
he  ﬁfth  question,  which  asks  whether  PIM2  may  not  be
ppropriate for  a  different  mix  of  cases,  is  the  hypothesis
aised in  the  present  study.  The  poor  performance  of  the
core in  patients  with  CCCs  and  in  the  total  sample,  which
ad 83.9%  of  patients  with  CCCs,  may  be  secondary  to  dif-
erences in  the  characteristics  between  the  study  samples
nd those  used  in  the  score  development.
Murphy-Filkins  et  al.  reported  that  changes  in  the  demo-
raphic characteristics  of  patients  and  in  the  prevalence
f diseases  alter  the  mix  of  cases,  which  may  inﬂuence
core performance.20 Perhaps,  with  the  recently  observed
ncrease in  the  prevalence  of  CCCs  among  patients  admit-Fonseca  JG,  Ferreira  AR
ed  to  the  PICU  and  the  observation  that  these  patients  have
 higher  mortality  rate  than  the  general  population,  it  will
e necessary  that  future  scores  for  outcome  prediction  use
his  condition  when  their  models  are  being  constructed.
The  SMR  of  1.65  (95%  CI:  1.26  to  2.04)  for  the  general
opulation and  of  1.75  (95%  CI:  1.31  to  2.19)  for  the  subgroup
f patients  with  CCCs  indicated  that  the  quality  of  health
are offered  at  the  PICU  for  these  patients  during  the  study
eriod was  worse  than  the  quality  of  health  care  offered  by
he PICUs  that  participated  in  the  PIM2  development  study
n the  period  between  1997  and  1999.  However,  the  SMR
f 1.14  (0.29  to  1.99)  for  patients  without  CCCs  indicated
hat the  quality  of  health  care  offered  at  the  PICU  for  this
ubgroup in  the  study  period  was  similar  to  the  quality  of
ealth care  offered  by  the  PICUs  that  participated  in  PIM2
evelopment study  between  1997  and  1999.
The  SMR  is  the  main  indicator  of  health  care  quality  in  the
ICU, and  is  part  of  the  ﬁrst  set  of  quality  indicators  that
ere submitted  to  the  Joint  Commission  on  Accreditation
f Healthcare  Organizations,  published  in  2005.21 However,
he accuracy  of  this  indicator  depends  on  the  capacity  of
he score  in  predicting  mortality  in  the  studied  population;8
hus,  in  addition  to  the  hypothesis  of  inadequate  quality  as
he cause  of  the  high  SMR  in  the  overall  study  population  and
n the  subgroup  of  patients  with  CCCs,  the  hypothesis  that
he PIM2  may  not  be  adequate  for  the  studied  population
annot be  ruled  out.
This  study  has  some  limitations.  The  principal  limitation
s the  fact  that  the  study  was  conducted  in  a  single  PICU,
aking it  difﬁcult  to  prove  the  hypothesis  and  subsequently,
he generalizability  of  the  ﬁndings.  Operating  conditions
equipment, medications,  and  staff)  in  the  studied  PICU  may
ot  be  similar  to  those  of  PICUs  in  developed  countries,
hich may  have  inﬂuenced  the  results.  Finally,  the  statis-
ical analysis  may  have  been  inﬂuenced  by  the  relatively
mall sample  size.
The PIM2  showed  poor  performance  in  the  subgroup  of
atients with  CCCs  and  the  overall  study  population,  which
ad 83.9%  of  patients  with  CCCs.  Although  the  poor  perfor-
ance of  the  score  may  be  secondary  to  the  quality  of  health
are offered  by  the  PICU,  the  hypothesis  that  the  difference
n characteristics  between  the  study  sample  and  the  sample
sed for  the  score  development  is  responsible  for  inadequate
erformance of  PIM2  cannot  be  ruled  out.  With  the  increas-
ng prevalence  of  CCC  patients  admitted  to  PICUs  observed
n recent  decades,  it  may  be  necessary  that  future  outcome
rediction scores  consider  this  condition  when  creating  their
odels.
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